Dawn Holt

CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model

P. Gimotty, Yanchun Li, M. Lipsky, 2009, Molecular Cancer Therapeutics.

Prostaglandin E2 EP receptors as therapeutic targets in breast cancer

A. Fulton, Dawn Holt, J. Reader, 2011, Cancer and Metastasis Reviews.

Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function

S. Ostrand-Rosenberg, Xinrong Ma, O. Goloubeva, 2009, Breast Cancer Research and Treatment.

Modulation of Host Natural Killer Cell Functions in Breast Cancer via Prostaglandin E2 Receptors EP2 and EP4

P. Collin, Xinrong Ma, A. Fulton, 2012, Journal of immunotherapy.

Prostaglandin E2 (PGE2) suppresses natural killer cell function primarily through the PGE2 receptor EP4

Xinrong Ma, A. Fulton, N. Kundu, 2011, Cancer Immunology, Immunotherapy.

Antimetastatic activity isolated from Colocasia esculenta (taro)

Chen-Yong Lin, Xinrong Ma, O. Goloubeva, 2012, Anti-cancer drugs.

A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasis

Xinrong Ma, O. Goloubeva, A. Fulton, 2013, Oncoimmunology.